Last Viewed
| Most Viewed
|
INAF - PT Indofarma TbkSector : Healthcare Industry : Drug Manufacturers—Specialty & GenericPT Indofarma Tbk, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. It offers laboratory, pharmaceutical, and health equipment; orthopedic and prosthetic equipment; industrial machinery for packaging, bottling, and canning; provides health consultancy services; and trades in laboratory equipment, pharmacy, and medicines. The company serves medicine product, medical and dental equipment, electromedical and electrotherapy equipment, herbal processing, and tea processing industries, as well as furniture industry for operations, medical care, and dental care. It also engages in marketing, trading, and distribution of products and related activities. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is headquartered in Bekasi, Indonesia. PT Indofarma Tbk is a subsidiary of PT Bio Farma. |
|
Dataid | Breakdown | Seq | TTM | 2022-12-31 |
---|---|---|---|---|
40002 | Enterprise Value | 1 | 1,032,097,846,168 | 3,839,593,771,622 |
14010 | Ps Ratio | 4 | 1 | 2 |
101 | Enterprises Value Revenue Ratio | 12 | 2 | 16 |
40001 | Market Cap | 16 | 505,180,602,500 | 3,564,157,625,000 |
102 | Enterprises Value E B I T D A Ratio | 20 | -18 | -12 |
14012 | Pb Ratio | 30 | 7 | 11 |
Dataid | Breakdown | Seq | TTM | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
---|---|---|---|---|---|---|---|
40002 | Enterprise Value | 1 | 1,032,097,846,168 | 1,989,797,530,276 | 2,271,000,187,151 | 2,491,412,409,122 | 3,839,593,771,622 |
14010 | Ps Ratio | 4 | 1 | 2 | 2 | 1 | 2 |
101 | Enterprises Value Revenue Ratio | 12 | 2 | 2 | 2 | 1 | 16 |
40001 | Market Cap | 16 | 505,180,602,500 | 1,518,641,075,000 | 1,952,538,525,000 | 2,215,976,262,500 | 3,564,157,625,000 |
102 | Enterprises Value E B I T D A Ratio | 20 | -18 | -31 | -45 | -51 | -12 |
14012 | Pb Ratio | 30 | 7 | 0 | 79 | 7 | 11 |
Dataid | Breakdown | Seq | TTM | 2022-12-31 | 2021-12-31 | 2020-12-31 |
---|---|---|---|---|---|---|
20189 | E B I T | 0 | -492,894,133,685 | -479,476,871,275 | 51,729,941,123 | 56,335,780,051 |
20304 | Write Off | 0 | 0 | 16,899,229,861 | 0 | -3,209,664,490 |
20091 | Net Income | 0 | -437,052,654,459 | -428,462,954,238 | -37,580,639,615 | 27,580,910 |
29004 | Basic E P S | 0 | -141 | -138 | -12 | 0 |
20190 | E B I T D A | 0 | -476,820,267,831 | -460,968,035,570 | 70,096,490,016 | 70,331,721,856 |
20007 | Amortization | 0 | 5,052,212,759 | 4,927,700,270 | 4,791,725,479 | 3,845,121,196 |
20046 | Gross Profit | 0 | -176,213,588,923 | -110,108,711,011 | 451,653,984,330 | 400,599,780,823 |
29009 | Diluted E P S | 0 | -141 | -138 | -12 | 0 |
20136 | Pretax Income | 0 | -540,913,429,773 | -517,557,861,610 | 8,773,199,052 | 18,081,602,176 |
20145 | Tax Provision | 0 | -103,837,879,648 | -89,070,190,015 | 46,344,440,278 | 18,051,581,467 |
20100 | Total Revenue | 0 | 684,912,941,481 | 1,144,108,230,742 | 2,901,986,532,879 | 1,715,587,654,399 |
20164 | Total Expenses | 0 | 1,174,745,616,271 | 1,609,262,614,895 | 2,845,441,250,300 | 1,650,086,366,512 |
20013 | Cost Of Revenue | 0 | 861,126,530,404 | 1,254,216,941,753 | 2,450,332,548,549 | 1,314,987,873,576 |
20177 | Interest Income | 0 | 5,419,765,224 | 4,543,191,579 | 1,841,468,848 | 1,104,999,265 |
20057 | Interest Expense | 0 | 48,019,296,088 | 38,080,990,335 | 42,956,742,071 | 38,254,177,875 |
20109 | Operating Income | 0 | -489,832,674,790 | -465,154,384,153 | 56,545,282,579 | 65,501,287,887 |
20316 | Normalized Income | 0 | -434,619,923,090 | -425,570,547,715 | -36,500,860,323 | -2,423,861,672 |
20108 | Operating Expense | 0 | 313,619,085,867 | 355,045,673,142 | 395,108,701,751 | 335,098,492,936 |
20112 | Operating Revenue | 0 | 684,912,941,481 | 1,144,108,230,742 | 2,901,986,532,879 | 1,715,587,654,399 |
20087 | Minority Interests | 0 | 22,895,666 | 24,717,357 | -9,398,389 | -2,439,799 |
20418 | Tax Rate For Calcs | 0 | 0 | 0 | 0 | 0 |
20095 | Net Interest Income | 0 | -42,599,530,864 | -33,537,798,756 | -41,115,273,223 | -37,149,178,610 |
20416 | Total Unusual Items | 0 | -3,010,685,608 | -3,493,654,157 | -1,384,332,426 | 3,268,590,109 |
29010 | Basic Average Shares | 0 | 3,099,267,500 | 3,099,267,500 | 3,099,267,500 | 2,758,091,000 |
20269 | Other Special Charges | 0 | -1,387,139,858 | 901,452,981 | 0 | -58,925,619 |
20287 | Rent And Landing Fees | 0 | 462,555,339 | 1,101,320,287 | 1,613,428,588 | 855,109,739 |
29011 | Diluted Average Shares | 0 | 3,099,267,500 | 3,099,267,500 | 3,099,267,500 | 2,758,091,000 |
20420 | Normalized E B I T D A | 0 | -473,809,582,223 | -457,474,381,413 | 71,480,822,442 | 67,063,131,747 |
20162 | Special Income Charges | 0 | -3,010,685,608 | -3,493,654,157 | -1,384,332,426 | 3,268,590,109 |
20315 | Reconciled Depreciation | 0 | 16,073,865,854 | 18,508,835,705 | 18,366,548,893 | 13,995,941,805 |
20312 | Other Operating Expenses | 0 | 75,211,022,892 | 89,220,544,008 | 103,187,343,830 | 74,257,155,540 |
20368 | Total Other Finance Cost | 0 | 0 | 18,000,000 | 348,954,891 | 2,156,729,011 |
20440 | Rent Expense Supplemental | 0 | 462,555,339 | 1,101,320,287 | 1,613,428,588 | 855,109,739 |
20314 | Reconciled Cost Of Revenue | 0 | 861,126,530,404 | 1,254,216,941,753 | 2,450,332,548,549 | 1,314,987,873,576 |
20419 | Tax Effect Of Unusual Items | 0 | -577,954,239 | -601,247,634 | -304,553,134 | 817,147,527 |
20225 | Impairment Of Capital Assets | 0 | 4,397,825,466 | 2,592,201,176 | 1,384,332,426 | 0 |
20018 | Depreciation Income Statement | 0 | 11,021,653,095 | 13,581,135,435 | 13,574,823,414 | 10,150,820,609 |
20075 | Interest Income Non Operating | 0 | 5,419,765,224 | 4,543,191,579 | 1,841,468,848 | 1,104,999,265 |
20158 | Selling And Marketing Expense | 0 | 33,601,695,815 | 48,523,191,990 | 43,733,279,823 | 44,960,773,659 |
20064 | Interest Expense Non Operating | 0 | 48,019,296,088 | 38,080,990,335 | 42,956,742,071 | 38,254,177,875 |
20093 | Net Income Common Stockholders | 0 | -437,052,654,459 | -428,462,954,238 | -37,580,639,615 | 27,580,910 |
20094 | Net Income Continuous Operations | 0 | -437,075,550,125 | -428,487,671,595 | -37,571,241,226 | 30,020,709 |
20045 | General And Administrative Expense | 0 | 37,200,571,164 | 42,940,336,304 | 45,749,651,185 | 41,158,084,045 |
20159 | Selling General And Administration | 0 | 70,802,266,979 | 91,463,528,294 | 89,482,931,008 | 86,118,857,704 |
20435 | Total Operating Income As Reported | 0 | -492,796,410,642 | -479,544,148,232 | 51,979,235,025 | 58,168,824,711 |
20412 | Other Non Operating Income Expenses | 0 | 0 | -5,359,971,964 | -3,675,343,067 | -17,652,514,978 |
20347 | Otherunder Preferred Stock Dividend | 0 | 0 | 0 | 0 | 0 |
20424 | Diluted N I Availto Com Stockholders | 0 | -437,052,654,459 | -428,462,954,238 | -37,580,639,615 | 27,580,910 |
20417 | Total Unusual Items Excluding Goodwill | 0 | -3,010,685,608 | -3,493,654,157 | -1,384,332,426 | 3,268,590,109 |
20077 | Net Non Operating Interest Income Expense | 0 | -42,599,530,864 | -33,537,798,756 | -41,115,273,223 | -37,149,178,610 |
20346 | Net Income Including Noncontrolling Interests | 0 | -437,075,550,125 | -428,487,671,595 | -37,571,241,226 | 30,020,709 |
20019 | Depreciation And Amortization In Income Statement | 0 | 16,073,865,854 | 18,508,835,705 | 18,366,548,893 | 13,995,941,805 |
20309 | Net Income From Continuing And Discontinued Operation | 0 | -437,052,654,459 | -428,462,954,238 | -37,580,639,615 | 27,580,910 |
20331 | Net Income From Continuing Operation Net Minority Interest | 0 | -437,052,654,459 | -428,462,954,238 | -37,580,639,615 | 27,580,910 |
Dataid | Breakdown | Seq | TTM | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
---|---|---|---|---|---|---|---|---|---|
20189 | E B I T | 0 | -492,894,133,685 | -67,047,702,783 | -54,579,828,316 | -51,904,489,059 | -479,476,871,275 | 51,729,941,123 | 56,335,780,051 |
20304 | Write Off | 0 | 0 | 0 | 0 | 258,937,500 | 16,899,229,861 | 0 | -3,209,664,490 |
20091 | Net Income | 0 | -437,052,654,459 | -71,353,853,799 | -58,549,542,326 | -61,796,493,726 | -428,462,954,238 | -37,580,639,615 | 27,580,910 |
29004 | Basic E P S | 0 | -141 | -141 | 0 | -20 | -138 | -12 | 0 |
20190 | E B I T D A | 0 | -476,820,267,831 | -63,668,986,637 | -50,100,488,220 | -48,840,647,370 | -460,968,035,570 | 70,096,490,016 | 70,331,721,856 |
20007 | Amortization | 0 | 5,052,212,759 | 1,261,007,732 | 1,272,145,233 | 1,249,870,232 | 4,927,700,270 | 4,791,725,479 | 3,845,121,196 |
20046 | Gross Profit | 0 | -176,213,588,923 | -3,365,866,901 | 9,274,570,920 | 4,329,200,026 | -110,108,711,011 | 451,653,984,330 | 400,599,780,823 |
29009 | Diluted E P S | 0 | -141 | -141 | 0 | -20 | -138 | -12 | 0 |
20136 | Pretax Income | 0 | -540,913,429,773 | -82,321,175,767 | -66,408,571,070 | -63,724,694,851 | -517,557,861,610 | 8,773,199,052 | 18,081,602,176 |
20145 | Tax Provision | 0 | -103,837,879,648 | -10,962,792,118 | -7,858,847,495 | -1,927,954,825 | -89,070,190,015 | 46,344,440,278 | 18,051,581,467 |
20100 | Total Revenue | 0 | 684,912,941,481 | 81,736,852,978 | 194,169,632,711 | 169,795,451,850 | 1,144,108,230,742 | 2,901,986,532,879 | 1,715,587,654,399 |
20164 | Total Expenses | 0 | 1,174,745,616,271 | 145,075,838,258 | 249,346,483,780 | 226,254,305,156 | 1,609,262,614,895 | 2,845,441,250,300 | 1,650,086,366,512 |
20013 | Cost Of Revenue | 0 | 861,126,530,404 | 85,102,719,879 | 184,895,061,791 | 165,466,251,824 | 1,254,216,941,753 | 2,450,332,548,549 | 1,314,987,873,576 |
20177 | Interest Income | 0 | 5,419,765,224 | 931,397,251 | 835,526,155 | 1,470,772,282 | 4,543,191,579 | 1,841,468,848 | 1,104,999,265 |
20057 | Interest Expense | 0 | 48,019,296,088 | 15,273,472,984 | 11,828,742,754 | 11,820,205,792 | 38,080,990,335 | 42,956,742,071 | 38,254,177,875 |
20109 | Operating Income | 0 | -489,832,674,790 | -63,338,985,280 | -55,176,851,069 | -56,458,853,306 | -465,154,384,153 | 56,545,282,579 | 65,501,287,887 |
20316 | Normalized Income | 0 | -434,619,923,090 | -70,080,974,837 | -58,549,542,326 | -61,796,493,726 | -425,570,547,715 | -36,500,860,323 | -2,423,861,672 |
20108 | Operating Expense | 0 | 313,619,085,867 | 59,973,118,379 | 64,451,421,989 | 60,788,053,332 | 355,045,673,142 | 395,108,701,751 | 335,098,492,936 |
20112 | Operating Revenue | 0 | 684,912,941,481 | 81,736,852,978 | 194,169,632,711 | 169,795,451,850 | 1,144,108,230,742 | 2,901,986,532,879 | 1,715,587,654,399 |
20087 | Minority Interests | 0 | 22,895,666 | 4,529,850 | 181,249 | 246,300 | 24,717,357 | -9,398,389 | -2,439,799 |
20418 | Tax Rate For Calcs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
20095 | Net Interest Income | 0 | -42,599,530,864 | -14,342,075,733 | -10,993,216,599 | -10,349,433,510 | -33,537,798,756 | -41,115,273,223 | -37,149,178,610 |
20416 | Total Unusual Items | 0 | -3,010,685,608 | -1,468,431,422 | 0 | -258,937,500 | -3,493,654,157 | -1,384,332,426 | 3,268,590,109 |
29010 | Basic Average Shares | 0 | 3,099,267,500 | 3,099,267,500 | 0 | 3,099,267,500 | 3,099,267,500 | 3,099,267,500 | 2,758,091,000 |
20269 | Other Special Charges | 0 | -1,387,139,858 | 0 | 0 | 0 | 901,452,981 | 0 | -58,925,619 |
20287 | Rent And Landing Fees | 0 | 462,555,339 | 160,557,022 | 468,931,422 | 292,803,164 | 1,101,320,287 | 1,613,428,588 | 855,109,739 |
29011 | Diluted Average Shares | 0 | 3,099,267,500 | 3,099,267,500 | 0 | 3,099,267,500 | 3,099,267,500 | 3,099,267,500 | 2,758,091,000 |
20420 | Normalized E B I T D A | 0 | -473,809,582,223 | -62,200,555,215 | -50,100,488,220 | -48,840,647,370 | -457,474,381,413 | 71,480,822,442 | 67,063,131,747 |
20162 | Special Income Charges | 0 | -3,010,685,608 | -1,468,431,422 | 0 | -258,937,500 | -3,493,654,157 | -1,384,332,426 | 3,268,590,109 |
20315 | Reconciled Depreciation | 0 | 16,073,865,854 | 3,378,716,146 | 4,479,340,096 | 3,063,841,689 | 18,508,835,705 | 18,366,548,893 | 13,995,941,805 |
20312 | Other Operating Expenses | 0 | 75,211,022,892 | 5,834,635,415 | 2,941,581,970 | 4,920,672,899 | 89,220,544,008 | 103,187,343,830 | 74,257,155,540 |
20368 | Total Other Finance Cost | 0 | 0 | 0 | 0 | 165,000,000 | 18,000,000 | 348,954,891 | 2,156,729,011 |
20440 | Rent Expense Supplemental | 0 | 462,555,339 | 160,557,022 | 468,931,422 | 292,803,164 | 1,101,320,287 | 1,613,428,588 | 855,109,739 |
20314 | Reconciled Cost Of Revenue | 0 | 861,126,530,404 | 85,102,719,879 | 184,895,061,791 | 165,466,251,824 | 1,254,216,941,753 | 2,450,332,548,549 | 1,314,987,873,576 |
20419 | Tax Effect Of Unusual Items | 0 | -577,954,239 | -195,552,460 | 0 | 0 | -601,247,634 | -304,553,134 | 817,147,527 |
20225 | Impairment Of Capital Assets | 0 | 4,397,825,466 | 1,468,431,422 | 0 | 0 | 2,592,201,176 | 1,384,332,426 | 0 |
20018 | Depreciation Income Statement | 0 | 11,021,653,095 | 2,117,708,414 | 3,207,194,863 | 1,813,971,457 | 13,581,135,435 | 13,574,823,414 | 10,150,820,609 |
20075 | Interest Income Non Operating | 0 | 5,419,765,224 | 931,397,251 | 835,526,155 | 1,470,772,282 | 4,543,191,579 | 1,841,468,848 | 1,104,999,265 |
20158 | Selling And Marketing Expense | 0 | 33,601,695,815 | 4,691,080,653 | 4,581,127,383 | 4,346,975,523 | 48,523,191,990 | 43,733,279,823 | 44,960,773,659 |
20064 | Interest Expense Non Operating | 0 | 48,019,296,088 | 15,273,472,984 | 11,828,742,754 | 11,820,205,792 | 38,080,990,335 | 42,956,742,071 | 38,254,177,875 |
20093 | Net Income Common Stockholders | 0 | -437,052,654,459 | -71,353,853,799 | -58,549,542,326 | -61,796,493,726 | -428,462,954,238 | -37,580,639,615 | 27,580,910 |
20094 | Net Income Continuous Operations | 0 | -437,075,550,125 | -71,358,383,649 | -58,549,723,575 | -61,796,740,026 | -428,487,671,595 | -37,571,241,226 | 30,020,709 |
20045 | General And Administrative Expense | 0 | 37,200,571,164 | 5,215,118,170 | 8,536,812,605 | 7,208,885,983 | 42,940,336,304 | 45,749,651,185 | 41,158,084,045 |
20159 | Selling General And Administration | 0 | 70,802,266,979 | 9,906,198,823 | 13,117,939,988 | 11,555,861,506 | 91,463,528,294 | 89,482,931,008 | 86,118,857,704 |
20435 | Total Operating Income As Reported | 0 | -492,796,410,642 | -67,047,702,783 | -54,579,828,316 | -51,739,489,059 | -479,544,148,232 | 51,979,235,025 | 58,168,824,711 |
20412 | Other Non Operating Income Expenses | 0 | 0 | -939,342,917 | -11,048,927 | 46,538,160 | -5,359,971,964 | -3,675,343,067 | -17,652,514,978 |
20347 | Otherunder Preferred Stock Dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
20424 | Diluted N I Availto Com Stockholders | 0 | -437,052,654,459 | -71,353,853,799 | -58,549,542,326 | -61,796,493,726 | -428,462,954,238 | -37,580,639,615 | 27,580,910 |
20417 | Total Unusual Items Excluding Goodwill | 0 | -3,010,685,608 | -1,468,431,422 | 0 | -258,937,500 | -3,493,654,157 | -1,384,332,426 | 3,268,590,109 |
20077 | Net Non Operating Interest Income Expense | 0 | -42,599,530,864 | -14,342,075,733 | -10,993,216,599 | -10,349,433,510 | -33,537,798,756 | -41,115,273,223 | -37,149,178,610 |
20346 | Net Income Including Noncontrolling Interests | 0 | -437,075,550,125 | -71,358,383,649 | -58,549,723,575 | -61,796,740,026 | -428,487,671,595 | -37,571,241,226 | 30,020,709 |
20019 | Depreciation And Amortization In Income Statement | 0 | 16,073,865,854 | 3,378,716,146 | 4,479,340,096 | 3,063,841,689 | 18,508,835,705 | 18,366,548,893 | 13,995,941,805 |
20309 | Net Income From Continuing And Discontinued Operation | 0 | -437,052,654,459 | -71,353,853,799 | -58,549,542,326 | -61,796,493,726 | -428,462,954,238 | -37,580,639,615 | 27,580,910 |
20331 | Net Income From Continuing Operation Net Minority Interest | 0 | -437,052,654,459 | -71,353,853,799 | -58,549,542,326 | -61,796,493,726 | -428,462,954,238 | -37,580,639,615 | 27,580,910 |
Dataid | Breakdown | Seq | TTM | 2022-12-31 | 2021-12-31 | 2020-12-31 |
---|---|---|---|---|---|---|
23531 | Net Debt | 0 | 0 | 353,072,684,403 | 216,796,393,945 | 294,456,019,194 |
23165 | Payables | 0 | 0 | 713,338,596,565 | 763,163,810,184 | 700,745,085,873 |
23139 | Net P P E | 0 | 0 | 462,994,107,143 | 477,146,968,455 | 471,386,167,543 |
23351 | Properties | 0 | 0 | 0 | 0 | 0 |
23386 | Total Debt | 0 | 0 | 627,213,057,075 | 604,837,873,565 | 457,492,829,123 |
23100 | Gross P P E | 0 | 0 | 792,403,403,491 | 797,382,651,159 | 762,806,526,652 |
23038 | Common Stock | 0 | 0 | 309,926,750,000 | 309,926,750,000 | 309,926,750,000 |
23045 | Current Debt | 0 | 0 | 193,038,118,748 | 203,089,852,578 | 91,858,005,417 |
23532 | Share Issued | 0 | 0 | 3,099,267,500 | 3,099,267,500 | 3,099,267,500 |
23220 | Total Assets | 0 | 0 | 1,534,000,446,508 | 2,011,879,396,142 | 1,713,334,658,849 |
23027 | Capital Stock | 0 | 0 | 309,926,750,000 | 309,926,750,000 | 309,926,750,000 |
23382 | Other Payable | 0 | 0 | 0 | 0 | 0 |
23028 | Cash Financial | 0 | 0 | 269,751,394,924 | 345,814,191,220 | 98,178,397,356 |
23123 | Long Term Debt | 0 | 0 | 429,785,960,579 | 394,520,732,587 | 360,776,420,282 |
23179 | Prepaid Assets | 0 | 0 | 108,084,014,120 | 230,503,350,672 | 254,326,634,001 |
23385 | Working Capital | 0 | 0 | -121,668,888,721 | 366,201,661,634 | 297,980,881,757 |
23000 | Accounts Payable | 0 | 0 | 525,884,210,913 | 568,662,774,491 | 602,640,634,256 |
23029 | Cash Equivalents | 0 | 0 | 0 | 35,000,000,000 | 60,000,009,149 |
23245 | Invested Capital | 0 | 0 | 709,183,205,851 | 1,105,906,367,557 | 882,956,224,754 |
23340 | Other Properties | 0 | 0 | 139,873,949,073 | 141,606,681,791 | 138,713,349,519 |
23132 | Minority Interest | 0 | 0 | -10,614,811 | 14,127,114 | 4,677,464 |
23342 | Other Receivables | 0 | 0 | 20,054,082,572 | 12,532,662,721 | 11,978,307,436 |
23204 | Retained Earnings | 0 | 0 | -616,295,611,197 | -187,832,656,959 | -150,252,017,344 |
23217 | Total Tax Payable | 0 | 0 | 187,454,385,652 | 194,501,035,693 | 98,104,451,617 |
23352 | Current Provisions | 0 | 0 | 27,677,712,214 | 39,029,536,684 | 7,784,828,001 |
23001 | Accounts Receivable | 0 | 0 | 173,136,177,340 | 379,499,459,835 | 559,825,743,144 |
23280 | Common Stock Equity | 0 | 0 | 86,359,126,524 | 508,295,782,392 | 430,321,799,055 |
23403 | Net Tangible Assets | 0 | 0 | 78,812,929,005 | 496,581,204,376 | 413,258,789,038 |
23215 | Stockholders Equity | 0 | 0 | 86,359,126,524 | 508,295,782,392 | 430,321,799,055 |
23383 | Tangible Book Value | 0 | 0 | 78,812,929,005 | 496,581,204,376 | 413,258,789,038 |
23374 | Total Capitalization | 0 | 0 | 516,145,087,103 | 902,816,514,979 | 791,098,219,337 |
23312 | Land And Improvements | 0 | 0 | 199,777,431,064 | 199,777,431,064 | 194,639,695,286 |
23469 | Other Equity Interest | 0 | 0 | 101,797,512,549 | 101,797,512,549 | 0 |
23393 | Ordinary Shares Number | 0 | 0 | 3,099,267,500 | 3,099,267,500 | 3,099,267,500 |
23155 | Other Intangible Assets | 0 | 0 | 7,546,197,519 | 11,714,578,016 | 17,063,010,017 |
23008 | Accumulated Depreciation | 0 | 0 | -329,409,296,348 | -320,235,682,704 | -291,420,359,109 |
23282 | Construction In Progress | 0 | 0 | 2,117,517,878 | 3,086,675,449 | 7,165,464,874 |
23380 | Capital Lease Obligations | 0 | 0 | 4,388,977,748 | 7,227,288,400 | 4,858,403,424 |
23030 | Cash And Cash Equivalents | 0 | 0 | 269,751,394,924 | 380,814,191,220 | 158,178,406,505 |
23262 | Gross Accounts Receivable | 0 | 0 | 357,785,030,108 | 549,718,448,426 | 687,119,833,292 |
23012 | Additional Paid In Capital | 0 | 0 | 81,120,060,644 | 81,120,060,644 | 81,120,060,644 |
23275 | Buildings And Improvements | 0 | 0 | 235,712,880,333 | 237,673,384,221 | 214,325,411,940 |
23126 | Long Term Equity Investment | 0 | 0 | 1,300,454,109 | 1,215,177,152 | 1,115,516,163 |
23163 | Other Short Term Investments | 0 | 0 | 39,000,000,000 | 35,000,000,000 | 0 |
23020 | Available For Sale Securities | 0 | 0 | 155,585,955 | 155,585,955 | 155,585,955 |
23319 | Machinery Furniture Equipment | 0 | 0 | 214,921,625,143 | 215,238,478,634 | 207,962,605,033 |
23048 | Current Capital Lease Obligation | 0 | 0 | 2,275,250,958 | 4,226,734,748 | 3,464,644,094 |
23552 | Fixed Assets Revaluation Reserve | 0 | 0 | 203,293,717,754 | 203,293,717,754 | 203,293,717,754 |
23127 | Long Term Capital Lease Obligation | 0 | 0 | 2,113,726,790 | 3,000,553,652 | 1,393,759,330 |
23098 | Goodwill And Other Intangible Assets | 0 | 0 | 7,546,197,519 | 11,714,578,016 | 17,063,010,017 |
23261 | Total Equity Gross Minority Interest | 0 | 0 | 86,348,511,713 | 508,309,909,506 | 430,326,476,519 |
23067 | Non Current Deferred Taxes Liabilities | 0 | 0 | 0 | 0 | 0 |
23259 | Total Liabilities Net Minority Interest | 0 | 0 | 1,447,651,934,795 | 1,503,569,486,636 | 1,283,008,182,330 |
23046 | Current Debt And Capital Lease Obligation | 0 | 0 | 195,313,369,706 | 207,316,587,326 | 95,322,649,511 |
23266 | Allowance For Doubtful Accounts Receivable | 0 | 0 | -184,648,852,768 | -170,218,988,591 | -127,294,090,148 |
23124 | Long Term Debt And Capital Lease Obligation | 0 | 0 | 431,899,687,369 | 397,521,286,239 | 362,170,179,612 |
23344 | Non Current Pension And Other Postretirement Benefit Plans | 0 | 0 | 30,506,306,393 | 60,859,762,042 | 84,086,064,395 |
Dataid | Breakdown | Seq | TTM | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
---|---|---|---|---|---|---|---|---|---|
23531 | Net Debt | 0 | 0 | 557,563,418,564 | 505,717,253,558 | 408,812,003,298 | 353,072,684,403 | 216,796,393,945 | 294,456,019,194 |
23165 | Payables | 0 | 0 | 701,116,703,816 | 701,880,935,263 | 755,486,517,648 | 713,338,596,565 | 763,163,810,184 | 700,745,085,873 |
23139 | Net P P E | 0 | 0 | 451,125,521,104 | 454,787,851,023 | 460,790,334,602 | 462,994,107,143 | 477,146,968,455 | 471,386,167,543 |
23351 | Properties | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
23386 | Total Debt | 0 | 0 | 771,724,358,103 | 768,320,627,099 | 662,569,625,298 | 627,213,057,075 | 604,837,873,565 | 457,492,829,123 |
23100 | Gross P P E | 0 | 0 | 797,048,812,873 | 795,351,303,873 | 795,005,465,789 | 792,403,403,491 | 797,382,651,159 | 762,806,526,652 |
23038 | Common Stock | 0 | 0 | 309,926,750,000 | 309,926,750,000 | 309,926,750,000 | 309,926,750,000 | 309,926,750,000 | 309,926,750,000 |
23045 | Current Debt | 0 | 0 | 352,713,637,249 | 348,242,728,277 | 238,972,553,602 | 193,038,118,748 | 203,089,852,578 | 91,858,005,417 |
23532 | Share Issued | 0 | 0 | 3,099,267,500 | 3,099,267,500 | 3,099,267,500 | 3,099,267,500 | 3,099,267,500 | 3,099,267,500 |
23220 | Total Assets | 0 | 0 | 1,491,062,009,957 | 1,559,064,749,732 | 1,576,237,915,603 | 1,534,000,446,508 | 2,011,879,396,142 | 1,713,334,658,849 |
23027 | Capital Stock | 0 | 0 | 309,926,750,000 | 309,926,750,000 | 309,926,750,000 | 309,926,750,000 | 309,926,750,000 | 309,926,750,000 |
23382 | Other Payable | 0 | 0 | 1,723,923,596 | 1,356,688,152 | 0 | 0 | 0 | 0 |
23028 | Cash Financial | 0 | 0 | 209,807,114,435 | 258,164,171,823 | 249,332,573,071 | 269,751,394,924 | 345,814,191,220 | 98,178,397,356 |
23123 | Long Term Debt | 0 | 0 | 414,656,895,750 | 415,638,697,104 | 419,172,022,767 | 429,785,960,579 | 394,520,732,587 | 360,776,420,282 |
23179 | Prepaid Assets | 0 | 0 | 139,046,087,533 | 129,109,597,070 | 111,165,044,798 | 108,084,014,120 | 230,503,350,672 | 254,326,634,001 |
23385 | Working Capital | 0 | 0 | -339,489,811,494 | -261,430,984,342 | -194,140,504,844 | -121,668,888,721 | 366,201,661,634 | 297,980,881,757 |
23000 | Accounts Payable | 0 | 0 | 488,074,592,120 | 498,978,674,350 | 563,939,495,164 | 525,884,210,913 | 568,662,774,491 | 602,640,634,256 |
23029 | Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 35,000,000,000 | 60,000,009,149 |
23245 | Invested Capital | 0 | 0 | 662,029,769,672 | 729,894,515,853 | 682,707,209,167 | 709,183,205,851 | 1,105,906,367,557 | 882,956,224,754 |
23340 | Other Properties | 0 | 0 | 143,008,266,256 | 141,575,747,256 | 141,568,007,256 | 139,873,949,073 | 141,606,681,791 | 138,713,349,519 |
23132 | Minority Interest | 0 | 0 | -15,572,210 | -11,042,360 | -10,861,111 | -10,614,811 | 14,127,114 | 4,677,464 |
23342 | Other Receivables | 0 | 0 | 34,532,469,845 | 34,342,199,486 | 39,203,626,759 | 20,054,082,572 | 12,532,662,721 | 11,978,307,436 |
23204 | Retained Earnings | 0 | 0 | -807,995,501,048 | -736,641,647,249 | -678,092,104,923 | -616,295,611,197 | -187,832,656,959 | -150,252,017,344 |
23217 | Total Tax Payable | 0 | 0 | 211,318,188,100 | 201,545,572,761 | 191,547,022,484 | 187,454,385,652 | 194,501,035,693 | 98,104,451,617 |
23352 | Current Provisions | 0 | 0 | 27,677,712,214 | 27,677,712,214 | 27,677,712,214 | 27,677,712,214 | 39,029,536,684 | 7,784,828,001 |
23001 | Accounts Receivable | 0 | 0 | 146,211,432,449 | 162,774,696,150 | 193,241,992,453 | 173,136,177,340 | 379,499,459,835 | 559,825,743,144 |
23280 | Common Stock Equity | 0 | 0 | -105,340,763,327 | -33,986,909,528 | 24,562,632,798 | 86,359,126,524 | 508,295,782,392 | 430,321,799,055 |
23403 | Net Tangible Assets | 0 | 0 | -109,099,812,649 | -39,006,966,582 | 18,268,780,511 | 78,812,929,005 | 496,581,204,376 | 413,258,789,038 |
23215 | Stockholders Equity | 0 | 0 | -105,340,763,327 | -33,986,909,528 | 24,562,632,798 | 86,359,126,524 | 508,295,782,392 | 430,321,799,055 |
23383 | Tangible Book Value | 0 | 0 | -109,099,812,649 | -39,006,966,582 | 18,268,780,511 | 78,812,929,005 | 496,581,204,376 | 413,258,789,038 |
23374 | Total Capitalization | 0 | 0 | 309,316,132,423 | 381,651,787,576 | 443,734,655,565 | 516,145,087,103 | 902,816,514,979 | 791,098,219,337 |
23312 | Land And Improvements | 0 | 0 | 199,777,431,064 | 199,777,431,064 | 199,777,431,064 | 199,777,431,064 | 199,777,431,064 | 194,639,695,286 |
23469 | Other Equity Interest | 0 | 0 | 101,797,512,549 | 101,797,512,549 | 101,797,512,549 | 101,797,512,549 | 101,797,512,549 | 0 |
23393 | Ordinary Shares Number | 0 | 0 | 3,099,267,500 | 3,099,267,500 | 3,099,267,500 | 3,099,267,500 | 3,099,267,500 | 3,099,267,500 |
23155 | Other Intangible Assets | 0 | 0 | 3,759,049,322 | 5,020,057,054 | 6,293,852,287 | 7,546,197,519 | 11,714,578,016 | 17,063,010,017 |
23008 | Accumulated Depreciation | 0 | 0 | -345,923,291,769 | -340,563,452,850 | -334,215,131,187 | -329,409,296,348 | -320,235,682,704 | -291,420,359,109 |
23282 | Construction In Progress | 0 | 0 | 1,648,554,878 | 1,522,554,878 | 2,117,517,878 | 2,117,517,878 | 3,086,675,449 | 7,165,464,874 |
23380 | Capital Lease Obligations | 0 | 0 | 4,353,825,104 | 4,439,201,718 | 4,425,048,929 | 4,388,977,748 | 7,227,288,400 | 4,858,403,424 |
23030 | Cash And Cash Equivalents | 0 | 0 | 209,807,114,435 | 258,164,171,823 | 249,332,573,071 | 269,751,394,924 | 380,814,191,220 | 158,178,406,505 |
23262 | Gross Accounts Receivable | 0 | 0 | 340,009,451,173 | 353,423,548,918 | 380,890,845,221 | 357,785,030,108 | 549,718,448,426 | 687,119,833,292 |
23012 | Additional Paid In Capital | 0 | 0 | 81,120,060,644 | 81,120,060,644 | 81,120,060,644 | 81,120,060,644 | 81,120,060,644 | 81,120,060,644 |
23275 | Buildings And Improvements | 0 | 0 | 238,030,942,409 | 237,650,942,409 | 236,963,041,325 | 235,712,880,333 | 237,673,384,221 | 214,325,411,940 |
23126 | Long Term Equity Investment | 0 | 0 | 1,300,454,109 | 1,300,454,109 | 1,300,454,109 | 1,300,454,109 | 1,215,177,152 | 1,115,516,163 |
23163 | Other Short Term Investments | 0 | 0 | 35,000,000,000 | 39,000,000,000 | 39,000,000,000 | 39,000,000,000 | 35,000,000,000 | 0 |
23020 | Available For Sale Securities | 0 | 0 | 155,585,955 | 155,585,955 | 155,585,955 | 155,585,955 | 155,585,955 | 155,585,955 |
23319 | Machinery Furniture Equipment | 0 | 0 | 214,583,618,266 | 214,824,628,266 | 214,579,468,266 | 214,921,625,143 | 215,238,478,634 | 207,962,605,033 |
23048 | Current Capital Lease Obligation | 0 | 0 | 3,148,892,713 | 3,234,269,327 | 2,170,828,601 | 2,275,250,958 | 4,226,734,748 | 3,464,644,094 |
23552 | Fixed Assets Revaluation Reserve | 0 | 0 | 203,293,717,754 | 203,293,717,754 | 203,293,717,754 | 203,293,717,754 | 203,293,717,754 | 203,293,717,754 |
23127 | Long Term Capital Lease Obligation | 0 | 0 | 1,204,932,391 | 1,204,932,391 | 2,254,220,328 | 2,113,726,790 | 3,000,553,652 | 1,393,759,330 |
23098 | Goodwill And Other Intangible Assets | 0 | 0 | 3,759,049,322 | 5,020,057,054 | 6,293,852,287 | 7,546,197,519 | 11,714,578,016 | 17,063,010,017 |
23261 | Total Equity Gross Minority Interest | 0 | 0 | -105,356,335,537 | -33,997,951,888 | 24,551,771,687 | 86,348,511,713 | 508,309,909,506 | 430,326,476,519 |
23067 | Non Current Deferred Taxes Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
23259 | Total Liabilities Net Minority Interest | 0 | 0 | 1,596,418,345,494 | 1,593,062,701,620 | 1,551,686,143,916 | 1,447,651,934,795 | 1,503,569,486,636 | 1,283,008,182,330 |
23046 | Current Debt And Capital Lease Obligation | 0 | 0 | 355,862,529,962 | 351,476,997,604 | 241,143,382,203 | 195,313,369,706 | 207,316,587,326 | 95,322,649,511 |
23266 | Allowance For Doubtful Accounts Receivable | 0 | 0 | -193,798,018,724 | -190,648,852,768 | -187,648,852,768 | -184,648,852,768 | -170,218,988,591 | -127,294,090,148 |
23124 | Long Term Debt And Capital Lease Obligation | 0 | 0 | 415,861,828,141 | 416,843,629,495 | 421,426,243,095 | 431,899,687,369 | 397,521,286,239 | 362,170,179,612 |
23344 | Non Current Pension And Other Postretirement Benefit Plans | 0 | 0 | 24,086,304,689 | 25,214,548,935 | 28,442,779,349 | 30,506,306,393 | 60,859,762,042 | 84,086,064,395 |
Dataid | Breakdown | Seq | TTM | 2022-12-31 | 2021-12-31 | 2020-12-31 |
---|---|---|---|---|---|---|
26127 | Sale Of P P E | 0 | 0 | 1,162,958,093 | 0 | 64,454,541 |
26185 | Free Cash Flow | 0 | -250,700,086,834 | -126,049,618,708 | 71,495,333,562 | 32,770,612,734 |
26027 | Changes In Cash | 0 | -59,882,969,703 | -111,015,893,167 | 222,636,965,463 | 6,824,727,815 |
26182 | Issuance Of Debt | 0 | 380,391,380,420 | 316,711,706,601 | 972,311,222,118 | 167,215,823,795 |
26016 | End Cash Position | 0 | 209,462,283,480 | 269,751,394,924 | 380,814,191,220 | 158,178,406,505 |
26112 | Purchase Of P P E | 0 | 4,598,606,052 | -12,468,231,296 | -21,270,495,384 | -10,896,749,428 |
26183 | Repayment Of Debt | 0 | -192,156,986,605 | -303,384,130,732 | -728,162,323,350 | -197,897,055,714 |
26125 | Sale Of Investment | 0 | 0 | 0 | 0 | 3,565,893,194 |
26005 | Capital Expenditure | 0 | 3,590,854,755 | -13,475,982,593 | -21,404,145,384 | -13,777,290,818 |
26012 | Financing Cash Flow | 0 | 188,234,393,814 | 13,327,575,869 | 244,148,898,768 | -30,681,231,919 |
26013 | Investing Cash Flow | 0 | 6,173,578,072 | -11,769,832,921 | -114,411,412,251 | -9,041,943,818 |
26110 | Purchase Of Investment | 0 | 0 | -4,000,000,000 | -95,000,000,000 | 0 |
26015 | Beginning Cash Position | 0 | 269,345,253,183 | 380,814,191,220 | 158,178,406,505 | 151,387,943,827 |
26223 | Classesof Cash Payments | 0 | -1,137,666,929,528 | -1,543,626,745,669 | -3,007,731,553,036 | -1,475,016,704,580 |
26247 | Interest Received C F I | 0 | 5,419,765,224 | 4,543,191,579 | 1,992,733,133 | 1,104,999,265 |
26099 | Long Term Debt Issuance | 0 | 433,671,163,591 | 298,285,326,357 | 277,860,000,000 | 0 |
26090 | Long Term Debt Payments | 0 | -197,449,187,203 | -207,544,235,466 | -20,100,843,132 | -3,917,199,503 |
26108 | Purchase Of Intangibles | 0 | 0 | -1,007,751,297 | -133,650,000 | -2,880,541,390 |
26101 | Short Term Debt Issuance | 0 | -53,279,783,171 | 18,426,380,244 | 694,451,222,118 | 167,215,823,795 |
26091 | Short Term Debt Payments | 0 | 5,292,200,598 | -95,839,895,266 | -708,061,480,218 | -193,979,856,211 |
26073 | Net Long Term Debt Issuance | 0 | 236,221,976,388 | 90,741,090,891 | 257,759,156,868 | -3,917,199,503 |
26165 | Net Other Investing Changes | 0 | 0 | 1,162,958,093 | 0 | 3,565,893,194 |
26119 | Net P P E Purchase And Sale | 0 | 5,761,564,145 | -11,305,273,203 | -21,270,495,384 | -10,832,294,887 |
26075 | Net Short Term Debt Issuance | 0 | -47,987,582,573 | -77,413,515,022 | -13,610,258,100 | -26,764,032,416 |
26072 | Net Issuance Payments Of Debt | 0 | 188,234,393,815 | 13,327,575,869 | 244,148,898,768 | -30,681,231,919 |
26063 | Effect Of Exchange Rate Changes | 0 | 344,830,954 | -46,903,129 | -1,180,748 | -34,265,138 |
26118 | Net Investment Purchase And Sale | 0 | 0 | -4,000,000,000 | -95,000,000,000 | 3,565,893,194 |
26117 | Net Intangibles Purchase And Sale | 0 | 0 | -1,007,751,297 | -133,650,000 | -2,880,541,390 |
26304 | Other Cash Adjustment Outside Changein Cash | 0 | 0 | 0 | 0 | 1 |
26220 | Cash Flowsfromusedin Operating Activities Direct | 0 | -254,290,941,589 | -112,573,636,115 | 92,899,478,946 | 46,547,903,552 |
26221 | Classesof Cash Receiptsfrom Operating Activities | 0 | 862,720,439,972 | 1,390,117,730,482 | 3,080,300,728,902 | 1,400,246,503,110 |
Dataid | Breakdown | Seq | TTM | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
---|---|---|---|---|---|---|---|---|---|
26127 | Sale Of P P E | 0 | 0 | 0 | 0 | 0 | 1,162,958,093 | 0 | 64,454,541 |
26185 | Free Cash Flow | 0 | -250,700,086,834 | -88,884,192,581 | -45,498,125,291 | -58,465,318,566 | -126,049,618,708 | 71,495,333,562 | 32,770,612,734 |
26027 | Changes In Cash | 0 | -59,882,969,703 | -48,401,747,657 | 8,688,413,123 | -20,300,851,221 | -111,015,893,167 | 222,636,965,463 | 6,824,727,815 |
26182 | Issuance Of Debt | 0 | 380,391,380,420 | 18,175,633,398 | 68,954,932,074 | 71,355,271,762 | 316,711,706,601 | 972,311,222,118 | 167,215,823,795 |
26016 | End Cash Position | 0 | 209,462,283,480 | 209,807,114,435 | 258,164,171,823 | 249,332,573,071 | 269,751,394,924 | 380,814,191,220 | 158,178,406,505 |
26112 | Purchase Of P P E | 0 | 4,598,606,052 | -2,057,510,903 | -1,773,577,662 | -356,783,239 | -12,468,231,296 | -21,270,495,384 | -10,896,749,428 |
26183 | Repayment Of Debt | 0 | -192,156,986,605 | 21,375,414,276 | -16,939,428,838 | -33,326,067,676 | -303,384,130,732 | -728,162,323,350 | -197,897,055,714 |
26125 | Sale Of Investment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,565,893,194 |
26005 | Capital Expenditure | 0 | 3,590,854,755 | -2,057,510,903 | -1,773,577,662 | -356,783,239 | -13,475,982,593 | -21,404,145,384 | -13,777,290,818 |
26012 | Financing Cash Flow | 0 | 188,234,393,814 | 39,551,047,673 | 52,015,503,236 | 38,029,204,086 | 13,327,575,869 | 244,148,898,768 | -30,681,231,919 |
26013 | Investing Cash Flow | 0 | 6,173,578,072 | -1,126,113,652 | 397,457,516 | -221,519,980 | -11,769,832,921 | -114,411,412,251 | -9,041,943,818 |
26110 | Purchase Of Investment | 0 | 0 | 0 | 0 | 0 | -4,000,000,000 | -95,000,000,000 | 0 |
26015 | Beginning Cash Position | 0 | 269,345,253,183 | 258,164,171,823 | 249,332,573,071 | 269,751,394,924 | 380,814,191,220 | 158,178,406,505 | 151,387,943,827 |
26223 | Classesof Cash Payments | 0 | -1,137,666,929,528 | -163,653,721,677 | -283,745,174,018 | -164,122,757,703 | -1,543,626,745,669 | -3,007,731,553,036 | -1,475,016,704,580 |
26247 | Interest Received C F I | 0 | 5,419,765,224 | 931,397,251 | 2,171,035,178 | 135,263,259 | 4,543,191,579 | 1,992,733,133 | 1,104,999,265 |
26099 | Long Term Debt Issuance | 0 | 433,671,163,591 | 18,175,633,398 | 82,258,262,815 | 34,951,941,021 | 298,285,326,357 | 277,860,000,000 | 0 |
26090 | Long Term Debt Payments | 0 | -197,449,187,203 | -1,509,633,803 | 0 | 0 | -207,544,235,466 | -20,100,843,132 | -3,917,199,503 |
26108 | Purchase Of Intangibles | 0 | 0 | 0 | 0 | 0 | -1,007,751,297 | -133,650,000 | -2,880,541,390 |
26101 | Short Term Debt Issuance | 0 | -53,279,783,171 | 0 | -13,303,330,741 | 36,403,330,741 | 18,426,380,244 | 694,451,222,118 | 167,215,823,795 |
26091 | Short Term Debt Payments | 0 | 5,292,200,598 | 22,885,048,079 | -13,606,175,081 | -33,326,067,676 | -95,839,895,266 | -708,061,480,218 | -193,979,856,211 |
26073 | Net Long Term Debt Issuance | 0 | 236,221,976,388 | 16,665,999,595 | 78,925,009,058 | 34,951,941,021 | 90,741,090,891 | 257,759,156,868 | -3,917,199,503 |
26165 | Net Other Investing Changes | 0 | 0 | 0 | 0 | 0 | 1,162,958,093 | 0 | 3,565,893,194 |
26119 | Net P P E Purchase And Sale | 0 | 5,761,564,145 | -2,057,510,903 | -1,773,577,662 | -356,783,239 | -11,305,273,203 | -21,270,495,384 | -10,832,294,887 |
26075 | Net Short Term Debt Issuance | 0 | -47,987,582,573 | 22,885,048,079 | -26,909,505,822 | 3,077,263,065 | -77,413,515,022 | -13,610,258,100 | -26,764,032,416 |
26072 | Net Issuance Payments Of Debt | 0 | 188,234,393,815 | 39,551,047,674 | 52,015,503,236 | 38,029,204,086 | 13,327,575,869 | 244,148,898,768 | -30,681,231,919 |
26063 | Effect Of Exchange Rate Changes | 0 | 344,830,954 | 44,690,269 | 143,185,628 | -117,970,631 | -46,903,129 | -1,180,748 | -34,265,138 |
26118 | Net Investment Purchase And Sale | 0 | 0 | 0 | 0 | 0 | -4,000,000,000 | -95,000,000,000 | 3,565,893,194 |
26117 | Net Intangibles Purchase And Sale | 0 | 0 | 0 | 0 | 0 | -1,007,751,297 | -133,650,000 | -2,880,541,390 |
26304 | Other Cash Adjustment Outside Changein Cash | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 1 |
26220 | Cash Flowsfromusedin Operating Activities Direct | 0 | -254,290,941,589 | -86,826,681,678 | -43,724,547,629 | -58,108,535,327 | -112,573,636,115 | 92,899,478,946 | 46,547,903,552 |
26221 | Classesof Cash Receiptsfrom Operating Activities | 0 | 862,720,439,972 | 83,103,153,587 | 249,098,958,703 | 111,246,148,194 | 1,390,117,730,482 | 3,080,300,728,902 | 1,400,246,503,110 |
Stock Code | Company Name | Date | Time | Previous Close | Open | Bid | Ask | Day's Range | Day's Range-Start | Day's Range-End | 52 Week Range | 52 Week Range-Start | 52 Week Range-End | Volume | Avg. Volume | Market Cap | Beta (5Y Monthly) | PE Ratio (TTM) | EPS (TTM) | Earnings Date | Forward Dividend & Yield | Forward Dividend | Forward Dividend Yield | Ex-Dividend Date | 1y Target Est | YTD Return |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
INAF | PT Indofarma Tbk | 2024-04-15 | At close: 04:14PM WIB | 260 | 260 | 248 | 250 | 250.00 - 260.00 | 250 | 260 | 250.00 - 725.00 | 250 | 725 | 81,300 | 226,756 | 774,817,000,000 | 0 | 0 | -141 | May 01, 2024 - May 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-04-12 | At close: 04:14PM WIB | 260 | 260 | 248 | 250 | 250.00 - 260.00 | 250 | 260 | 250.00 - 725.00 | 250 | 725 | 81,300 | 233,840 | 774,817,000,000 | 0 | 0 | -141 | Apr 16, 2024 - Apr 17, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-04-11 | At close: 04:14PM WIB | 260 | 260 | 248 | 250 | 250.00 - 260.00 | 250 | 260 | 250.00 - 725.00 | 250 | 725 | 81,300 | 231,041 | 774,817,000,000 | 0 | 0 | -141 | Apr 12, 2024 - Apr 13, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-04-10 | At close: 04:14PM WIB | 260 | 260 | 248 | 250 | 250.00 - 260.00 | 250 | 260 | 250.00 - 725.00 | 250 | 725 | 81,300 | 230,505 | 774,817,000,000 | 0 | 0 | -141 | Apr 12, 2024 - Apr 13, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-04-05 | At close: 04:14PM WIB | 260 | 260 | 254 | 240 | 250.00 - 260.00 | 250 | 260 | 250.00 - 725.00 | 250 | 725 | 81,300 | 232,812 | 774,817,000,000 | 0 | 0 | -141 | May 01, 2024 - May 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-04-04 | At close: 04:14PM WIB | 274 | 266 | 262 | 248 | 260.00 - 266.00 | 260 | 266 | 260.00 - 725.00 | 260 | 725 | 118,200 | 243,067 | 805,810,000,000 | 0 | 0 | -141 | Apr 04, 2024 - Apr 05, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-04-03 | At close: 04:00PM WIB | 276 | 276 | 276 | 270 | 274.00 - 276.00 | 274 | 276 | 274.00 - 725.00 | 274 | 725 | 30,500 | 271,929 | 849,200,000,000 | 0 | 0 | -141 | May 01, 2024 - May 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-04-02 | At close: 04:00PM WIB | 306 | 276 | 276 | 276 | 276.00 - 276.00 | 276 | 276 | 276.00 - 725.00 | 276 | 725 | 530,000 | 282,489 | 855,398,000,000 | 0 | 0 | -141 | May 01, 2024 - May 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-04-01 | At close: 04:14PM WIB | 310 | 310 | 306 | 304 | 306.00 - 310.00 | 306 | 310 | 306.00 - 725.00 | 306 | 725 | 89,400 | 294,281 | 948,377,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-03-29 | At close: 04:07PM WIB | 322 | 314 | 312 | 308 | 310.00 - 314.00 | 310 | 314 | 310.00 - 725.00 | 310 | 725 | 196,800 | 294,281 | 960,774,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-03-28 | At close: 04:07PM WIB | 322 | 314 | 312 | 308 | 310.00 - 314.00 | 310 | 314 | 310.00 - 725.00 | 310 | 725 | 196,800 | 304,884 | 960,774,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-03-27 | At close: 04:07PM WIB | 356 | 322 | 0 | 0 | 322.00 - 322.00 | 322 | 322 | 322.00 - 730.00 | 322 | 730 | 431,100 | 292,539 | 997,965,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-03-26 | At close: 04:05PM WIB | 394 | 356 | 0 | 0 | 356.00 - 356.00 | 356 | 356 | 356.00 - 730.00 | 356 | 730 | 363,100 | 323,274 | 1,103,000,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-03-25 | At close: 04:00PM WIB | 436 | 394 | 0 | 0 | 394.00 - 394.00 | 394 | 394 | 380.00 - 730.00 | 380 | 730 | 478,500 | 328,945 | 1,221,000,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-03-22 | At close: 04:01PM WIB | 398 | 398 | 436 | 434 | 398.00 - 436.00 | 398 | 436 | 380.00 - 730.00 | 380 | 730 | 2,360,200 | 292,703 | 1,351,000,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-03-21 | At close: 03:41PM WIB | 394 | 0 | 0 | 0 | 0.0000 - 0.0000 | 0 | 0 | 0 | 0 | 340,937 | 0 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |||
INAF | PT Indofarma Tbk | 2024-03-14 | As of 01:43PM WIB. Market open. | 400 | 402 | 400 | 406 | 398.00 - 404.00 | 398 | 404 | 380.00 - 795.00 | 380 | 795 | 222,100 | 756,305 | 1,240,000,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-03-13 | At close: 04:08PM WIB | 396 | 396 | 400 | 402 | 394.00 - 416.00 | 394 | 416 | 380.00 - 795.00 | 380 | 795 | 155,000 | 756,737 | 1,240,000,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-03-11 | At close: 04:00PM WIB | 394 | 392 | 396 | 398 | 392.00 - 398.00 | 392 | 398 | 380.00 - 800.00 | 380 | 800 | 14,100 | 766,868 | 1,227,000,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-03-08 | At close: 04:00PM WIB | 394 | 392 | 396 | 398 | 392.00 - 398.00 | 392 | 398 | 380.00 - 815.00 | 380 | 815 | 14,100 | 775,772 | 1,227,000,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-03-05 | At close: 04:00PM WIB | 390 | 394 | 386 | 392 | 386.00 - 394.00 | 386 | 394 | 380.00 - 815.00 | 380 | 815 | 17,500 | 897,991 | 1,196,000,000,000 | 0 | 0 | -142 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-03-04 | At close: 03:35PM WIB | 388 | 386 | 388 | 390 | 386.00 - 392.00 | 386 | 392 | 380.00 - 825.00 | 380 | 825 | 49,500 | 1,018,544 | 1,209,000,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-03-01 | At close: 04:03PM WIB | 386 | 382 | 386 | 388 | 382.00 - 392.00 | 382 | 392 | 380.00 - 840.00 | 380 | 840 | 25,000 | 1,039,182 | 1,203,000,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-02-28 | At close: 03:41PM WIB | 388 | 388 | 382 | 388 | 380.00 - 388.00 | 380 | 388 | 380.00 - 840.00 | 380 | 840 | 223,500 | 1,021,291 | 1,196,000,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-02-27 | At close: 04:14PM WIB | 390 | 388 | 386 | 392 | 386.00 - 394.00 | 386 | 394 | 384.00 - 840.00 | 384 | 840 | 302,100 | 1,016,722 | 1,203,000,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-02-26 | At close: 04:12PM WIB | 392 | 392 | 388 | 390 | 388.00 - 396.00 | 388 | 396 | 384.00 - 850.00 | 384 | 850 | 193,600 | 1,014,825 | 1,209,000,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk | 2024-02-23 | At close: 04:00PM WIB | 394 | 394 | 390 | 392 | 390.00 - 398.00 | 390 | 398 | 384.00 - 850.00 | 384 | 850 | 147,200 | 1,013,096 | 1,215,000,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk (INAF.JK) | 2024-02-22 | At close: 04:00PM WIB | 396 | 396 | 392 | 394 | 392.00 - 398.00 | 392 | 398 | 384.00 - 850.00 | 384 | 850 | 52,300 | 1,013,038 | 1,221,000,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 | |
INAF | PT Indofarma Tbk (INAF.JK) | 2024-02-21 | At close: 04:00PM WIB | 400 | 384 | 396 | 400 | 384.00 - 406.00 | 384 | 406 | 384.00 - 880.00 | 384 | 880 | 126,200 | 1,011,976 | 1,227,000,000,000 | 0 | 0 | -141 | Apr 01, 2024 - Apr 02, 2024 | N/A (N/A) | 0 | 0 | May 03, 2013 | 0 |
Stock Code | Company Name | Date | Market Cap (intraday) | Enterprise Value | Trailing P/E | Forward P/E | PEG Ratio (5 Yr Expected) | Price/Sales (ttm) | Price/Book (mrq) | Enterprise Value/Revenue | Enterprise Value/EBITDA | Beta (5Y Monthly) | 52-Week Change | S&P500 52-Week Change | 52 Week High | 52 Week Low | 50-Day Moving Average | 200-Day Moving Average | Avg Vol (3 Month) | Avg Vol (10 Day) | Shares Outstanding | Implied Shares Outstanding | Float | % Held By Insiders | % Held By Institutions | Shares Short | Short Ratio | Short % Of Float | Short % Of Shares Outstanding | Shares Short (prior Month) | Forward Annual Dividend Rate | Forward Annual Dividend Yield | Trailing Annual Dividend Rate | Trailing Annual Dividend Yield | 5 Year Average Dividend Yield | Payout Ratio | Dividend Date | Ex-Dividend Date | Last Split Factor | Last Split Date | Fiscal Year Ends | Most Recent Quarter (mrq) | Profit Margin | Operating Margin (ttm) | Return On Assets (ttm) | Return On Equity (ttm) | Revenue (ttm) | Revenue Per Share (ttm) | Quarterly Revenue Growth (yoy) | Gross Profit (ttm) | EBITDA | Net Income Avi To Common (ttm) | Diluted EPS (ttm) | Quarterly Earnings Growth (yoy) | Total Cash (mrq) | Total Cash Per Share (mrq) | Total Debt (mrq) | Total Debt/Equity (mrq) | Current Ratio (mrq) | Book Value Per Share (mrq) | Operating Cash Flow (ttm) | Levered Free Cash Flow (ttm) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
INAF | PT Indofarma Tbk | 2024-04-15 | 774,820,000,000 | 1,300,000,000,000 | 0 | 0 | 0 | 1 | 7 | 2 | -3 | 0 | 0 | 0 | 725 | 250 | 369 | 492 | 234 | 170 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-04-12 | 774,820,000,000 | 1,300,000,000,000 | 0 | 0 | 0 | 1 | 7 | 2 | -3 | 0 | 0 | 0 | 725 | 250 | 379 | 498 | 231 | 211 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-04-11 | 774,820,000,000 | 1,300,000,000,000 | 0 | 0 | 0 | 1 | 7 | 2 | -3 | 0 | 0 | 0 | 725 | 250 | 379 | 498 | 231 | 211 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-04-10 | 774,820,000,000 | 1,300,000,000,000 | 0 | 0 | 0 | 1 | 7 | 2 | -3 | 0 | 0 | 0 | 725 | 250 | 379 | 498 | 231 | 211 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-04-05 | 849,200,000,000 | 1,380,000,000,000 | 0 | 0 | 0 | 1 | 7 | 2 | -3 | 0 | 0 | 0 | 725 | 0 | 400 | 507 | 243 | 461 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-04-04 | 855,400,000,000 | 1,380,000,000,000 | 0 | 0 | 0 | 1 | 7 | 2 | -3 | 0 | 0 | 0 | 725 | 0 | 404 | 509 | 272 | 461 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-04-03 | 855,400,000,000 | 1,380,000,000,000 | 0 | 0 | 0 | 1 | 7 | 2 | -3 | 0 | 0 | 0 | 725 | 0 | 408 | 511 | 282 | 412 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-04-02 | 948,380,000,000 | 1,480,000,000,000 | 0 | 0 | 0 | 1 | 7 | 2 | -3 | 0 | 0 | 0 | 725 | 0 | 412 | 512 | 294 | 409 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-04-01 | 960,770,000,000 | 1,490,000,000,000 | 0 | 0 | 0 | 1 | 7 | 2 | -3 | 0 | 0 | 0 | 725 | 0 | 412 | 512 | 294 | 409 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-03-29 | 960,770,000,000 | 1,490,000,000,000 | 0 | 0 | 0 | 1 | 7 | 2 | -3 | 0 | 0 | 0 | 725 | 310 | 416 | 514 | 305 | 412 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-03-28 | 997,960,000,000 | 1,520,000,000,000 | 0 | 0 | 0 | 1 | 7 | 2 | -3 | 0 | 0 | 0 | 730 | 0 | 422 | 516 | 293 | 300 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-03-27 | 1,350,000,000,000 | 1,880,000,000,000 | 0 | 0 | 0 | 2 | 7 | 3 | -4 | 0 | 0 | 0 | 730 | 0 | 424 | 517 | 323 | 333 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-03-26 | 1,350,000,000,000 | 1,880,000,000,000 | 0 | 0 | 0 | 2 | 7 | 3 | -4 | 0 | 0 | 0 | 730 | 0 | 426 | 518 | 329 | 375 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-03-25 | 1,350,000,000,000 | 1,880,000,000,000 | 0 | 0 | 0 | 2 | 7 | 3 | -4 | 0 | 0 | 0 | 730 | 380 | 426 | 518 | 329 | 375 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-03-22 | 1,230,000,000,000 | 1,760,000,000,000 | 0 | 0 | 0 | 2 | 7 | 3 | -4 | 0 | 0 | 0 | 730 | 0 | 430 | 520 | 341 | 79 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-03-21 | 1,220,000,000,000 | 1,750,000,000,000 | 0 | 0 | 0 | 2 | 7 | 3 | -4 | 0 | 0 | 0 | 730 | 380 | 430 | 520 | 341 | 79 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-03-14 | 1,240,000,000,000 | 1,770,000,000,000 | 0 | 0 | 0 | 2 | 7 | 3 | -4 | 0 | 0 | 0 | 795 | 0 | 449 | 526 | 757 | 62 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-03-13 | 1,230,000,000,000 | 1,750,000,000,000 | 0 | 0 | 0 | 2 | 7 | 3 | -4 | 0 | 0 | 0 | 800 | 0 | 458 | 529 | 767 | 99 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-03-11 | 1,230,000,000,000 | 1,750,000,000,000 | 0 | 0 | 0 | 2 | 7 | 3 | -4 | 0 | 0 | 0 | 800 | 380 | 458 | 529 | 763 | 99 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-03-08 | 1,220,000,000,000 | 1,750,000,000,000 | 0 | 0 | 0 | 2 | 7 | 3 | -4 | 0 | 0 | 0 | 815 | 380 | 463 | 530 | 776 | 112 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-03-05 | 1,200,000,000,000 | 1,730,000,000,000 | 0 | 0 | 0 | 2 | 7 | 3 | -4 | 0 | 0 | 0 | 825 | 0 | 484 | 535 | 1,020,000 | 155 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -142 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-03-04 | 1,200,000,000,000 | 1,730,000,000,000 | 0 | 0 | 0 | 2 | 7 | 3 | -4 | 0 | 0 | 0 | 825 | 380 | 484 | 535 | 1,020,000 | 155 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-03-01 | 1,200,000,000,000 | 1,720,000,000,000 | 0 | 0 | 0 | 2 | 7 | 3 | -4 | 0 | 0 | 0 | 840 | 0 | 491 | 537 | 1,020,000 | 213 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-02-28 | 1,200,000,000,000 | 1,730,000,000,000 | 0 | 0 | 0 | 2 | 7 | 3 | -4 | 0 | 0 | 0 | 840 | 0 | 494 | 539 | 1,020,000 | 200 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-02-27 | 1,210,000,000,000 | 1,740,000,000,000 | 0 | 0 | 0 | 2 | 7 | 3 | -4 | 0 | 0 | 0 | 850 | 0 | 498 | 541 | 1,010,000 | 160 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk | 2024-02-26 | 1,210,000,000,000 | 1,740,000,000,000 | 0 | 0 | 0 | 2 | 7 | 3 | -4 | 0 | 0 | 0 | 850 | 0 | 498 | 541 | 1,010,000 | 160 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk (INAF.JK) | 2024-02-23 | 1,220,000,000,000 | 1,750,000,000,000 | 0 | 0 | 0 | 2 | 7 | 1 | -4 | 0 | 0 | 0 | 850 | 0 | 502 | 544 | 1,010,000 | 162 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk (INAF.JK) | 2024-02-22 | 1,230,000,000,000 | 1,750,000,000,000 | 0 | 0 | 0 | 2 | 7 | 3 | -4 | 0 | 0 | 0 | 850 | 384 | 502 | 544 | 1,010,000 | 162 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
INAF | PT Indofarma Tbk (INAF.JK) | 2024-02-21 | 1,240,000,000,000 | 1,770,000,000,000 | 0 | 0 | 0 | 2 | 7 | 3 | -4 | 0 | 0 | 0 | 880 | 384 | 505 | 546 | 1,010,000 | 151 | 3,100,000,000 | 0 | 227,550,000 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | May 03, 2013 | N/A | N/A | Dec 31, 2022 | Sep 30, 2023 | -64 | -79 | -19 | -398 | 684,910,000,000 | 221 | -75 | 0 | -479,070,000,000 | -437,050,000,000 | -141 | 0 | 209,810,000,000 | 68 | 771,720,000,000 | 0 | 1 | -34 | -254,290,000,000 | -11,300,000,000 |
Stock Price (1 Minute)
| Stock Price (2 Minutes)
| Stock Price (5 Minutes)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Price (15 Minutes)
| Stock Price (30 Minutes)
| Stock Price (30 Minutes)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Price (90 Minutes)
| Stock Price (1 Day)
| Stock Price (5 Days)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Price (1 Week)
| Stock Price (1 Month)
| Stock Price (3 Months)
|
Dividends AmountN/A | Dividends YieldsN/A | SplitsN/A |
Disclaimer This website is intended for informational purposes only. We do not provide any buying or selling recommendations or investment advice regarding stocks or any other financial instruments. The content provided on this website is for educational and informational purposes and should not be considered as financial advice. Investing in stocks or any financial asset carries risks, and individuals should conduct their own research or consult with a qualified financial advisor before making any investment decisions. The information provided on this website may not be suitable for all individuals, and we do not guarantee the accuracy, completeness, or reliability of the information presented. Any opinions, analyses, reviews, or recommendations expressed on this website are solely those of the authors and do not represent the opinions or endorsements of any company or entity. We do not endorse or promote any specific stocks, investment strategies, or financial products. By using this website, you agree that you are solely responsible for any investment decisions you make, and you agree to indemnify and hold harmless this website and its owners, operators, and affiliates from any losses, damages, or liabilities arising from your use of the information provided. Please be aware that past performance is not indicative of future results, and investing in the financial markets involves inherent risks. We encourage you to exercise caution and prudence when making investment decisions and to seek professional advice as needed.
Free-Counters